CLINICAL_TRIALS
trial_result
· 2011-10-10
Clinical Trial Update: Hypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized Prostate Cancer [Phase 1, Phase 2]
Summary
This clinical trial update reports completed Phase 1/2 results for hypofractionated radiotherapy (55 Gy in 16 fractions over 4 weeks) for localized prostate can…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Alberta Health services | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED